Skip to main content
padlock icon - secure page this page is secure

The Socio-Political Economy of Pharmaceutical Mergers: A Case Study of Sanofi and Aventis

Buy Article:

$53.00 + tax (Refund Policy)

This article critically analyses the events leading up to the 2004 merger between the pharmaceutical companies Sanofi-Synthelabo and Aventis. It reveals the social, commercial and political complexities and challenges of a merger process in which the defence of French national interests and regional capabilities competed with traditional commercial’ narratives before the deal was closed. The merger is analysed within the broader context of contemporary debates, within the strategic management and innovation systems literature, about the process of global innovation in pharmaceuticals, industry consolidation and the discursive socio-political discourses that underlie cross-border merger and acquisition activity. The article critically evaluates the competing criteria adopted by government and industry to justify different merger scenarios and considers the implications for pharmaceutical innovation, industry consolidation and M&A theory.

No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Document Type: Research Article

Affiliations: ESRC Innogen Centre, University of Edinburgh, UK

Publication date: December 1, 2006

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more